Electroanalytical overview: the electroanalytical detection of theophylline

Crapnell, Robert D ORCID: https://orcid.org/0000-0002-8701-3933 and Banks, Craig E ORCID: https://orcid.org/0000-0002-0756-9764 (2021) Electroanalytical overview: the electroanalytical detection of theophylline. Talanta Open, 3. p. 100037. ISSN 2666-8319

Preview

Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (3MB) | Preview

Abstract

In this overview, we explore the electroanalytical determination of theophylline. Theophylline finds use as a bronchodilator for treating diseases such as asthma and chronic obstructive pulmonary disease (COPD). There is a need to measure the concentration of theophylline in pharmaceuticals for QA/QC purposes as well as in plasma samples to ensure the doses of theophylline are at the correct therapeutic levels. If the concentration levels of theophylline deviate from the therapeutic levels (10–20 µg/mL for asthma), then patients can experience adverse effects. As such, there is a desire to progress from traditional laboratory based techniques to portable rapid testing. In this overview, we review the endeavours directed to the development of theophylline electroanalytical sensors, noting current and future trends.